ZYLOXTB Releases Updated Board and Committee Structure

Bulletin Express
05/13

Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) announced the composition of its Board of Directors and the three standing committees as of 13 May 2026.

The nine-member Board is led by Executive Chairman Dr. Jonathon Zhong Zhao. Other executive directors include Mr. Yang Xie (employee director) and Dr. Zheng Li. Non-executive directors are Dr. Steven Dasong Wang and Mr. Dongfang Li. Independent non-executive directors comprise Dr. Jian Ji, Ms. Yun Qiu and Dr. Xiang Qian.

Committee assignments are as follows:

• Audit Committee: Chaired by Ms. Yun Qiu with Dr. Jian Ji and Dr. Xiang Qian as members. • Remuneration Committee: Chaired by Dr. Jian Ji; members include Mr. Dongfang Li and Dr. Xiang Qian. • Nomination Committee: Chaired by Dr. Jonathon Zhong Zhao; members are Dr. Jian Ji and Ms. Yun Qiu.

The disclosure provides investors with clarity on Zylox-Tonbridge’s governance framework, highlighting a balanced mix of executive, non-executive and independent oversight across key board committees.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10